These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Use of captopril in arterial hypertension with a stable and malignant course]. Lordkipanidze NL Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):111-7. PubMed ID: 6145432 [No Abstract] [Full Text] [Related]
8. Captopril: pharmacology, metabolism and disposition. Migdalof BH; Antonaccio MJ; McKinstry DN; Singhvi SM; Lan SJ; Egli P; Kripalani KJ Drug Metab Rev; 1984; 15(4):841-69. PubMed ID: 6437780 [TBL] [Abstract][Full Text] [Related]
9. Acute and chronic effects of captopril on the renin-angiotensin and kallikrein-kinin systems affecting blood pressure and natriuresis. Kida O Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):343-52. PubMed ID: 3894731 [No Abstract] [Full Text] [Related]
10. [Effect of angiotensin I converting enzyme inhibitor (captopril) on blood pressure and bradykinin in patients with excessive aldosterone secretion]. Haruyama K; Mizuno K; Yamazaki M; Toki T; Yaginuma K; Fukuchi S Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):437-44. PubMed ID: 6381834 [No Abstract] [Full Text] [Related]
11. Captopril and renal function. Reubi FC Contrib Nephrol; 1984; 43():159-70. PubMed ID: 6386324 [No Abstract] [Full Text] [Related]
12. [Use of captopril in cardiology practice]. Zhukova IM Kardiologiia; 1983 Apr; 23(4):110-4. PubMed ID: 6345885 [No Abstract] [Full Text] [Related]
13. Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy. Heel RC; Brogden RN; Speight TM; Avery GS Drugs; 1980 Dec; 20(6):409-52. PubMed ID: 7009133 [TBL] [Abstract][Full Text] [Related]
14. Captopril in mild and moderate essential hypertension: physiological and biochemical monitoring. Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J Acta Med Scand Suppl; 1983; 677():105-9. PubMed ID: 6322529 [No Abstract] [Full Text] [Related]
15. Acute effects of captopril on cardiopulmonary hemodynamics and renin-angiotensin-aldosterone and bradykinin profile in hypertension. Mookherjee S; Anderson GH; Eich R; Hill N; Smulyan H; Streeten DH; Vardan S; Warner R Am Heart J; 1983 Jan; 105(1):106-12. PubMed ID: 6336874 [TBL] [Abstract][Full Text] [Related]
16. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension]. Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470 [TBL] [Abstract][Full Text] [Related]
17. Effects of captopril on blood pressure in neurogenic hypertensive dogs. Montastruc P; Montastruc JL Arch Farmacol Toxicol; 1983 Apr; 9(1):47-52. PubMed ID: 6354107 [No Abstract] [Full Text] [Related]
18. [Hypotensive effects of angiotensin I converting enzyme inhibitor, and relationship between kallikrein-kinin system and renin-angiotensin-aldosterone system]. Mizuno K; Gotoh M; Haruyama K; Ikeda K; Hashimoto S; Fukuchi S Nihon Jinzo Gakkai Shi; 1983 Jan; 25(1):59-66. PubMed ID: 6341658 [No Abstract] [Full Text] [Related]
19. Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients. McGrath BP; Matthews PG; Johnston CI Clin Exp Pharmacol Physiol; 1980; 7(5):487-91. PubMed ID: 7004680 [TBL] [Abstract][Full Text] [Related]
20. Influence of captopril treatment on angiotensin II receptors and angiotensinogen in the brain of spontaneously hypertensive rats. Schelling P; Felix D Hypertension; 1983; 5(6):935-42. PubMed ID: 6317552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]